Cetaxim comes as a iv/im injection with 250 mg/vial of Cefotaxime, from Globe Pharmaceuticals Ltd. It may be started before the exact infecting organism is identified, or when the bacteria are known to be sensitive to it.
There are 24 brands of Cefotaxime listed in Bangladesh. The lowest listed price is Cefot 250 mg/vial IV/IM Injection at ৳ 50.15 per unit.
What is Cetaxim 250 mg/vial IV/IM Injection?
The iv/im injection Cetaxim contains Cefotaxime and is made by Globe Pharmaceuticals Ltd. Doctors use it for infections such as septicaemia and respiratory tract infections including acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess. Cetaxim comes as a 250 mg/vial iv/im injection and is given by a healthcare professional. Ask your doctor or pharmacist if you are unsure about it.
Uses of Cetaxim
It may be started before the exact infecting organism is identified, or when the bacteria are known to be sensitive to it. Cetaxim is used to treat bacterial infections caused by organisms that are sensitive to Cetaximaxime. Cetaxim is used for certain bacterial infections, including septicaemia and respiratory tract infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and infections after surgery. Your doctor will decide if it is suitable for you.
How to use Cetaxim
Cetaxim 250 mg/vial is an injection given by a doctor or nurse, either into a vein or into a muscle. Cetaxim is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Swallow the iv/im injection with a glass of water. The doctor decides the dose and how long it is given, based on how severe the infection is and the person's condition.
Side effects of Cetaxim
Side effects are reported relatively infrequently and are usually mild and temporary. Side effects with Cetaximaxime are relatively infrequent and are generally mild and transient. Tell your doctor if you notice any side effect. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Cetaxim must not be given to anyone who has had a hypersensitivity reaction to Cetaximaxime or to other cephalosporin antibiotics. Cetaxim should not be used by anyone who has shown hypersensitivity to Cetaximaxime or to the cephalosporin group of antibiotics. It should be used with caution in people with a history of gastrointestinal disease. Tell your doctor about any allergies, kidney problems, pregnancy or breastfeeding before treatment.
Frequently asked questions
Why is Cetaxim prescribed?
It may be started before the exact infecting organism is identified, or when the bacteria are known to be sensitive to it. Cetaxim is used to treat bacterial infections caused by organisms that are sensitive to Cetaximaxime.
How is Cetaxim used?
Cetaxim 250 mg/vial is an injection given by a doctor or nurse, either into a vein or into a muscle. Cetaxim is given as an injection by a healthcare professional.
What should I watch for while using Cetaxim?
Side effects are reported relatively infrequently and are usually mild and temporary. Side effects with Cetaximaxime are relatively infrequent and are generally mild and transient.
Is Cetaxim safe for everyone?
Cetaxim must not be given to anyone who has had a hypersensitivity reaction to Cetaximaxime or to other cephalosporin antibiotics. Cetaxim should not be used by anyone who has shown hypersensitivity to Cetaximaxime or to the cephalosporin group of antibiotics.
Cefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis ... Read moreCefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and postoperative chest infections Urinary Tract Infections such as acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria Soft-tissue Infection such as cellulitis, peritonitis and wound infections Bone and Joint Infections such as osteomyelitis, septic arthritis Obstetric and gynaecological infections: such as pelvic inflammatory disease Gonorrhoea particularly when penicillin has failed or is unsuitable Other Bacterial Infections: meningitis and other sensitive infections suitable for parenteral antibiotic therapy Prophylaxis: The administration of Cefotaxime prophylactically may reduce the incidence of certain post operative infections in patients undergoing surgical procedures that are classified as contaminated or potentially contaminated or in clean operation where infection would have serious effects.
Pharmacology
Cefotaxime binds to 1 or more of the penicillin binding proteins (PBPs) which inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Cefotaxime is a broad spectrum bactericidal 3rd generation parenteral cephalosporin antibiotic. Cefotaxime is exceptionally active against gram-negative organisms sensitive or resistant to first or second generation cephalosporins. It is similar to other cephalosporins in activity against gram-positive bacteria.
Dosage & Administration
Adults: The recommended dosage for mild to moderate infections is 1 gm every 12 hourly. However, dosage may be varied according to the severity of infection, sensitivity of causative organisms and condition of the patient. In severe infections dosage may be increased up to 12 gm daily given in 3 or 4 divided doses. For infections caused by sensitive Pseudomonas spp. daily doses of greater than 6 gm will usually be required
Children: The usual dosage range is 100-150 mg/kg/day in 2 to 4 divided doses. However, in very severe infections doses of up to 200 mg/kg/day may be required.
Neonates: The recommended dosage is 50 mg/kg/day in 2 to 4 divided doses. In severe infections 150-200 mg/kg/day, in divided doses, have been given.
Dosage in gonorrhoea: 500 mg as a single dose.
Interaction
Increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics.
Contraindications
Cefotaxime is contraindicated in patients who have shown hypersensitivity to cefotaxime or the cephalosporin group of antibiotics.
Side Effects
Adverse reactions to Cefotaxime have occurred relatively infrequently and have generally been mild and transient. Effects reported include candidiasis, rashes, fever, transient rises in liver transaminase and/or alkaline phosphatase and diarrhoea. As with all cephalosporins, pseudomembranous colitis may rarely occur during treatment. If this occurs the drug should be stopped and specific treatment instituted.As with other cephalosporins, changes in renal function have been rarely observed with high doses of Cefotaxime. Administration of high doses of cephalosporins particularly in patients with renal insufficiency may result in encephalopathy. Hypersensitivity reactions have been reported, these include skin rashes, drug fever and very rarely anaphylaxis.
Pregnancy & Lactation
Although studies in animals have not shown any adverse effect on the developing foetus, the safety of Cefotaxime in human pregnancy has not been established. Consequently, Cefotaxime should not be administered during pregnancy especially during first trimester, without carefully weighing the expected benefit against possible risks. Cefotaxime is excreted in the milk.
Precautions & Warnings
Cefotaxime should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. Because high and prolonged antibiotic concentrations can occur from usual doses in patients with transient or persistent reduction of urinary output because of renal insufficiency, the total daily dosage should be reduced when Cefotaxime is administered to such patients. Continued dosage should be determined by degree of renal impairment, severity of infection, and susceptibility of the causative organism. There is no clinical evidence supporting the necessity of changing the dosage of Cefotaxime in patients with even profound renal dysfunction.
Storage Conditions
Store below 25°C, protected from light and moisture. Use reconstituted solution immediately. Reconstituted solution is stable for up to 24 h if stored between 2° to 8°C.
Alternative brands of Cefotaxime
Other brands with the same generic name, cheapest first.